home / stock / cmvlf / cmvlf message board
Subject | By | Source | When |
---|---|---|---|
$CMVLF recent news/filings | stocktrademan | investorshub | 04/12/2015 2:44:22 PM |
$CMVLF recent news/filings | stocktrademan | investorshub | 08/19/2014 3:18:38 PM |
Stock Tracker: Latest Cellectis Romainvil (CMVLF) Headlines Cellectis and Servier announce collabora | Stock_Tracker | investorshangout | 03/09/2014 2:20:48 PM |
chartguy89: CMVLF 6.70 Stock Charts $CMVLF 1 Month Chart | chartguy89 | investorshangout | 03/06/2014 5:59:13 PM |
Stock Tracker: CMVLF Recent News Cellectis and Servier announce collaboration in allogeneic cell the | Stock_Tracker | investorshangout | 03/04/2014 9:54:30 PM |
chartguy89: CMVLF Stock Charts Last: -0.55 Monday, February 24, 2014 at 8:02:12 PM $CMVLF 1 | chartguy89 | investorshangout | 02/25/2014 1:02:24 AM |
News, Short Squeeze, Breakout and More Instantly...
Cellectis Romainville Ord Company Name:
CMVLF Stock Symbol:
OTCMKTS Market:
This novel editing approach might unlock new strategies for the treatment of metabolic and neurological diseases Non-viral circular ssDNA delivery associated to TALEN® gene editing allows high levels of gene insertion in long-term repopulating HSPCs NEW YORK, April 22, ...
NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the publication of a new ...
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that preliminary data exp...